Primary Record
Berzosertib
- In stock
- 7,868 g
- Purity
- 98.2 %
- CAS
- 1232416-25-9
Compound Identifiers & Properties
- CAS
- 1232416-25-9
- PubChem CID
- 59472121
- SMILES
- CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N
- Canonical SMILES
- CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1
Names & Synonyms
- Berzosertib
- VE-822
- 1232416-25-9
- berzosertibum
- Berzosertib [USAN]
- VX-970
- VE822
- VX-970;Berzosertib
- A1EIE
- VX970
- RefChem:917027
- BERZOSERTIB [INN]
- L423PRV3V3
- UNII-L423PRV3V3
- Berzosertib (USAN/INN)
- Berzosertib (VE-822)
- AGN-PC-0CXKB3
- VE 822
- D0H6GI
- VE-822 (Berzosertib)?
- MFCD27976794
- BERZOSERTIB [WHO-DD]
- C24H25N5O3S
- GTPL8003
- orb1701146
- SCHEMBL3061890
- CHEMBL3989870
- SCHEMBL30514080
- EX-A529
- CHEBI:131166
- VE-822 (VX-970)
- VX 970
- BDBM350085
- DTXSID601025940
- GLXC-90024
- HMS3653C05
- HMS3747I11
- M6620
- AOB87712
- BCP07948
- 2789AH
- BDBM50226746
- NSC777718
- s7102
- US10208027, Compound II-1
- US10208027, Compound II-2
- US10208027, Compound II-3
- US10208027, Compound II-4
- ZINC96170459
- AKOS025404905
- ACN-029396
- CCG-264673
- CS-1861
- DB11794
- EBC-224029
- NSC-777718
- SB17265
- KS-00001D76
- M-6620
- NCGC00386313-07
- AC-32951
- AK174892
- AS-17041
- BC600537
- CID:59472121
- DA-46989
- FV137734
- HY-13902
- QC-10953
- SY057018
- 5-(4-(isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-amine
- SID:312525275
- AB0098627
- B1383
- FT-0700136
- NS00073122
- SW220202-1
- 2-Pyrazinamine, 3-[3-[4-[(methylamino)methyl]phenyl]-5-isoxazolyl]-5-[4-[(1-methylethyl)sulfonyl]phenyl]-
- 3-(3-{4-[(METHYLAMINO)METHYL]PHENYL}-1,2-OXAZOL-5-YL)-5-[4-(PROPANE-2-SULFONYL)PHENYL]PYRAZIN-2-AMINE
- J3.353.324A
- A13289
- D11148
- M 6620
- A857986
- 2-Pyrazinamine, 3-(3-(4-((methylamino)methyl)phenyl)-5-isoxazolyl)-5-(4-((1-methylethyl)sulfonyl)phenyl)-
- 3-[3-[4-(methylaminomethyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine
- BRD-K04701033-001-01-3
- BRD-K04701033-001-03-9
- BRD-K04701033-001-04-7
- Q27089129
- 3-[3-[4-[(Methylamino)methyl]phenyl]-5-isoxazolyl]-5-[4-[(1-methylethyl)sulfonyl]phenyl]-2-pyrazinamine
- C000598331
- 3-(3-(4-((METHYLAMINO)METHYL)PHENYL)-1,2-OXAZOL-5-YL)-5-(4-(PROPANE-2-SULFONYL)PHENYL)PYRAZIN-2-AMINE
- 5-(4-isopropylsulfonylphenyl)-3-[3-[4-(methylaminomethyl)phenyl]isoxazol-5-yl]pyrazin-2-amine
- 5-(4-(isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-amine.
- 2-Amino-5-[4-(isopropylsulfonyl)phenyl]-3-[3-[4-[(methylamino)methyl]phenyl]-5-isoxazolyl]pyrazine
- 3-(3-(4-((Methylamino)methyl)phenyl)-5-isoxazolyl)-5-(4-((1-methylethyl)sulfonyl)phenyl)-2-pyrazinamine
- 3-(3-(4-(methylaminomethyl)phenyl)-1,2-oxazol-5-yl)-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine
- 3-[3-[4-(Methylaminomethyl)phenyl]-5-isoxazolyl]-5-[4-(isopropylsulfonyl)phenyl]-2-pyrazineamine
- 5-(4-(isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-amine(VE-822)
- Synthesis of 3-[3-[4-[dideuterio(methylamino)methyl]phenyl]isoxazol-5-yl]-5-(4-isopropylsulfonylphenyl)pyrazin-2-amine